So-called
serious "cancerologic literature" thrives on guardedness galore by
generously employing such conjunctional defenses as provided, usually,
perhaps, although, and the like.
Take
for example, the following lines from the Truth About Cancer-by Cameron, C.S
(Collier Books, New York, 1967):
“Today
the patient with cancer of stomach can look with hopefulness toward a cure
provided the tumour is confined to the stomach and provided
the surgeon is thoroughly competent to do whatever necessary to remove all
of it.”
Very
recently, we had the opportunity of going through two
diametrically opposite findings presented by two cancer
‘scholars’ on the relationship between aspirin and cancer. One
study conducted by Dr. Eva Schernhammer of Harvard Medical School and
Brigham and Women’s Hospital of Boston, concluded “daily aspirin may
cause pancreatic cancer”.
On
26th October 2003 Dr. Eva told the media people “initially we
expected that aspirin would protect against pancreatic cancer,
especially since its preventive role in colorectal cancer has been well
documented. However, now it appears that we need to examine the
relationship more thoroughly.”
The
Times, London, published another report, titled, “Daily aspirin may
become a cure-all for the over 60s”. It said: “A conference on the
uses of aspirin in preventing cancer, held in London on 10th
November, 2003 heard, however, that there was increasing evidence of
aspirin’s beneficial effects across a range of disease. "
“The
conference was told that there was also strong evidence to suggest that
aspirin could help prevent breast, prostate or bowel cancer”. [see, The
Statesman, edit page,12/11/03]
On
seeing the state of the cancer research Noble Laureate Sir
Macfarlane Burnet had out-rightly rejected the utility of cancer research. (
Please visit the page on 'Noble Laureates on Cancer')